Lunesta is the trade name for a medication containing the active ingredient eszopiclone, used for the treatment of insomnia.

Indications for Use:

• Insomnia: Difficulty falling asleep or maintaining sleep.

Contraindications:

• Known hypersensitivity to eszopiclone or any components of the drug.
• Severe hepatic dysfunction.
• Pregnancy and Breastfeeding: Use is not recommended due to insufficient safety data.

Side Effects:

1. Common:
   • Bitter or metallic taste in the mouth.
   • Headache, drowsiness, dry mouth.
2. Rare but Serious:
   • Allergic reactions, including angioedema.
   • Behavioral changes, hallucinations, suicidal thoughts.
3. Other:
   • Dizziness, nausea, vomiting.
   • Impaired coordination, amnesia.

Special Instructions:

1. Risk of Dependence and Abuse:
   • Eszopiclone is classified as a controlled substance (C-IV) due to its potential for dependence and abuse.
2. Complex Sleep Behaviors:
   • There is a risk of patients engaging in activities such as driving, eating, or making phone calls during sleep, with no recollection afterward.
3. Interaction with Alcohol and CNS Depressants:
   • Co-administration with alcohol or other central nervous system (CNS) depressants can increase sedation and is not recommended.
4. Discontinuation:
   • Abrupt discontinuation after prolonged use may lead to withdrawal symptoms. Gradual dose reduction under medical supervision is recommended.

Precautions:

Before starting treatment with Lunesta, consult a healthcare provider to evaluate the appropriateness of therapy and determine the optimal dosage. Self-medication is strongly discouraged and may lead to adverse effects.

• Film-coated tablets for oral use.
• Available in 1 mg, 2 mg and 3 mg strengths.